The START Center

We are thrilled to announce the expansion of our capabilities to support early-phase hematological cancer trials globally! Read the press release: lnkd.in/e9QCRMUz

We’re excited to share @VicMorenoGarcia's article on how wearables are transforming cancer trials! His findings show that daily walking distance predicts survival better than traditional methods like ECOG. Learn more about this game-changing research: lnkd.in/e4rnQc-V

BT7480, a Nectin-4/CD137 Bicycle tumor–targeted immune cell agonist, showcased clinical activity as a single agent in patients with varying levels of Nectin-4– and CD137-expressing tumors. @TheSTARTCenter @SITCancer #SITC2024 #oncology onclive.com/view/bt7480-sh…

BT7480 Shows Preliminary Activity in Nectin-4+, CD137+ Tumors @TheSTARTCenter @SITCancer #SITC2024 #oncology onclive.com/view/bt7480-sh…

Check out Dr. @VicMorenoGarcia's interview with @OncLive on CLN-619, a novel IgG1 antibody targeting MICA & MICB in solid tumors. In a phase 1 trial, CLN-619 showed immune responses, boosting T-cell & NK cell activity. Listen to Dr. Moreno’s interview: onclive.com/view/dr-moreno…

Just presented at #SITC2024 BNT-116 + cemiplimab shows promise in advanced #NSCLC patients previously treated with anti-PD-1: 2 partial Responses. Promising efficacy with manageable safety—exciting progress in #CancerVaccines! @hospital_fjd @TheSTARTCenter

Yesterday our team created “SuperPower” kits for children battling pediatric cancer in local hospitals. Each kit was filled with little pieces of hope - all meant to spark courage and resilience in young hearts. This was such a memorable & impactful day!

We're excited to announce our new #clinicalresearch early-phase oncology site at Fundación Rioja Salud! Read more in the press release: startresearch.com/the-start-cent…

Ireland's 1st Phase 1 Cancer Trials Unit opened @MaterDublin! ➡️Investigational treatments ➡️Free access for eligible patients 🌟A major step forward @aduffy74 @geosullivanc in #CancerResearch @STARTDublinPh1 @TheSTARTCenter @hseNCCP @myESMO @VicMorenoGarcia @AmitaPatnaikMD

Exciting news! START’s Dr. @AmitaPatnaikMD joins Dr. @ShikhaJainMD on the #OncologyOverdrive podcast. She shares her unique journey in oncology, the critical role of early-phase trials, and START's mission to bring novel treatments to patients. Listen now! tinyurl.com/mpb5sda4

Delighted to have had Minister for Public Expenditure Paschal Donohoe @Paschald at the #MaterHospital for the official launch of @STARTDublinPh1, the Republic of Ireland’s first dedicated Phase I Clinical Trials Unit

Launching @STARTDublinPh1, Min. Donohoe said: “It gives me great pleasure to officially open the Republic’s first dedicated Phase I Oncology Clinical Trials Unit... START Dublin will be a vital place to give hope and access to the newest medicines for those with advanced cancer.”

Y por fin una mesa de ensayos clínicos fase 1 en #SEOM24 Muchas gracias por la invitación a participar como moderador - gran discusión sobre los últimos avances. @_SEOM @Hospital_FJD @TheSTARTCenter

@VicMorenoGarcia @_SEOM @Hospital_FJD You’re incredible, @VicMorenoGarcia!!! 🎉

CEO of the #MaterHospital, Alan Sharp said today: “Given the commitment of START Dublin to accelerate the passage from trials to treatment, this should bring hope to patients, their families and the dedicated oncology team here in the Mater.” @MaterCancer @TheSTARTCenter

We’re excited to share that Dr. @AmitaPatnaikMD has been named to the PharmaVoice 100 list as a “Cancer Care Visionary”! Congratulations, Dr. Patnaik! 🎉 startresearch.com/starts-amita-p…

We’re thrilled to announce that Dr. Chris Takimoto has joined START as our CMO! With 250+ early-phase oncology trials led and a proven track record in drug development, Chris will be a key driver in advancing our mission. Welcome, Chris! startresearch.com/the-start-cent…

Catch the teaser here:

On demand! Catch our panel session on #ADC in the future of oncology clinical research: startresearch.wistia.com/medias/94oi2s0…

A huge congratulations to our very own @Thernandezg for achieving her #PhD today! We are so proud of you & lucky to have you on our team! 🥳